Quarterly report · Q3
2370.TEDINET S100P0C7
Period2021-10-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥470m | 2021-10-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥683m | 2020-10-01 → 2021-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥512m | 2020-10-01 → 2021-06-30 | Standalone | Net sales |
| Operating income | −¥988m | 2021-10-01 → 2022-06-30 | Standalone | Operating income |
| Operating income | −¥792m | 2020-10-01 → 2021-06-30 | Standalone | Operating income |
| Ordinary income | −¥984m | 2021-10-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | −¥871m | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥577m | 2020-10-01 → 2021-06-30 | Standalone | Ordinary income |
| Profit before tax | −¥985m | 2021-10-01 → 2022-06-30 | Standalone | Income before income taxes |
| Profit before tax | −¥545m | 2020-10-01 → 2021-06-30 | Standalone | Income before income taxes |
| Net income | −¥989m | 2021-10-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | −¥843m | 2020-10-01 → 2021-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥549m | 2020-10-01 → 2021-06-30 | Standalone | Profit loss |
| Total assets | ¥6.3bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥5.4bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥5.7bn | at 2021-06-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥539m | at 2022-06-30 | Standalone | Liabilities |
| Total liabilities | ¥475m | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.7bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.9bn | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.2bn | at 2021-06-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.8bn | at 2022-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.1bn | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥-5.11 | 2021-10-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.5 | 2022-04-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.88 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.21 | 2020-10-01 → 2021-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-0.22 | 2021-04-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.4% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 90.8% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.2% | at 2021-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 211,730,423 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 178,750,423 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 177,730,423 | at 2021-06-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-06-30 | −¥386m |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥194,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥194,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2021-10-01 → 2022-06-30 | −¥425m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥470m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥470m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2021-10-01 → 2022-06-30 | −¥178m |
| —segment total | revenue | 2021-10-01 → 2022-06-30 | ¥470m |
| —segment total | revenue external | 2021-10-01 → 2022-06-30 | ¥470m |
| —segment total | segment profit | 2021-10-01 → 2022-06-30 | −¥603m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | −¥385m |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥143,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥143,000 |
| jpcrp040300-q3r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | −¥319m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥512m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥512m |
| jpcrp040300-q3r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2020-10-01 → 2021-06-30 | −¥88m |
| —segment total | revenue | 2020-10-01 → 2021-06-30 | ¥512m |
| —segment total | revenue external | 2020-10-01 → 2021-06-30 | ¥512m |
| —segment total | segment profit | 2020-10-01 → 2021-06-30 | −¥407m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 318
| Item | Context | Value | Unit |
|---|---|---|---|
| Gain on investments in partnership noi | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Reversal of allowance for doubtful accounts noi | Prior1YTDDuration_NonConsolidatedMember | 3750000 | JPY |
| Reversal of allowance for doubtful accounts noi | CurrentYTDDuration_NonConsolidatedMember | 4650000 | JPY |
| Income for cancellation of manufacturing noi | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Income for cancellation of manufacturing noi | CurrentYTDDuration_NonConsolidatedMember | 7699000 | JPY |
| Other noi | Prior1YTDDuration_NonConsolidatedMember | 2828000 | JPY |
| Other noi | CurrentYTDDuration_NonConsolidatedMember | 1156000 | JPY |
| Non operating income | Prior1YTDDuration_NonConsolidatedMember | 221374000 | JPY |
| Non operating income | CurrentYTDDuration_NonConsolidatedMember | 18582000 | JPY |
| Interest expenses noe | Prior1YTDDuration_NonConsolidatedMember | 241000 | JPY |
| Interest expenses noe | CurrentYTDDuration_NonConsolidatedMember | 79000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration_NonConsolidatedMember | 10000 | JPY |
| Foreign exchange losses noe | CurrentYTDDuration_NonConsolidatedMember | 250000 | JPY |
| Loss on investments in partnership noe | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Loss on investments in partnership noe | CurrentYTDDuration_NonConsolidatedMember | 7535000 | JPY |
| Stock issuance cost noe | Prior1YTDDuration_NonConsolidatedMember | 6555000 | JPY |
| Stock issuance cost noe | CurrentYTDDuration_NonConsolidatedMember | 6471000 | JPY |
| Non operating expenses | Prior1YTDDuration_NonConsolidatedMember | 6807000 | JPY |
| Non operating expenses | CurrentYTDDuration_NonConsolidatedMember | 14336000 | JPY |
| Ordinary income | Prior1YTDDuration_NonConsolidatedMember | -577464000 | JPY |
| Ordinary income | CurrentYTDDuration_NonConsolidatedMember | -984160000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration_NonConsolidatedMember | 8267000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Gain on reversal of subscription rights to shares ei | Prior1YTDDuration_NonConsolidatedMember | 24432000 | JPY |
| Gain on reversal of subscription rights to shares ei | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Extraordinary income | Prior1YTDDuration_NonConsolidatedMember | 32699000 | JPY |
| Extraordinary income | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration_NonConsolidatedMember | 527000 | JPY |
| Extraordinary loss | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Extraordinary loss | CurrentYTDDuration_NonConsolidatedMember | 527000 | JPY |
| Income before income taxes | Prior1YTDDuration_NonConsolidatedMember | -544764000 | JPY |
| Income before income taxes | CurrentYTDDuration_NonConsolidatedMember | -984688000 | JPY |
| Income taxes current | Prior1YTDDuration_NonConsolidatedMember | 4092000 | JPY |
| Income taxes current | CurrentYTDDuration_NonConsolidatedMember | 4092000 | JPY |
| Income taxes deferred | Prior1YTDDuration_NonConsolidatedMember | -74000 | JPY |
| Income taxes deferred | CurrentYTDDuration_NonConsolidatedMember | -38000 | JPY |
| Income taxes | Prior1YTDDuration_NonConsolidatedMember | 4018000 | JPY |
| Income taxes | CurrentYTDDuration_NonConsolidatedMember | 4054000 | JPY |
| Profit loss | Prior1YTDDuration_NonConsolidatedMember | -548783000 | JPY |
| Profit loss | CurrentYTDDuration_NonConsolidatedMember | -988743000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | 512112000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | 143000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | 512256000 | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration_NonConsolidatedMember | 512256000 | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000ContractCellManufacturingBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_jpcrp040300-q3r_E05351-000CellularAndTissueBasedProductBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |